These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Clarifications regarding bumetanide for neonatal seizures.
    Author: Staley KJ.
    Journal: Epilepsia; 2022 Jul; 63(7):1863-1867. PubMed ID: 35524444.
    Abstract:
    A recent Phase II randomized, controlled trial of bumetanide as an adjunctive treatment for neonatal seizures showed a robust efficacy signal and no evidence of toxicity. Concerns regarding bumetanide as an adjunctive anticonvulsant are addressed here. An adequately powered multi-institutional trial is needed to accurately determine efficacy.
    [Abstract] [Full Text] [Related] [New Search]